Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: A population-based cohort study

European Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2013, Pages 629-639

  Tsai, Hsin Hui ^a,b   Lin, Hsiang Wen ^a,b   Chien, Chun Ru ^b,c   Li, Tsai Chung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anticoagulants; Antiplatelets; Chinese medications; Concurrent use; Digoxin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CHINESE DRUG; CLOPIDOGREL; DIGOXIN; DIPYRIDAMOLE; HEPARIN; TICLOPIDINE; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ALTERNATIVE MEDICINE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART DISEASE; HUMAN; HYPERTENSION; INCIDENCE; INCOME; MALE; MEDICAL HISTORY; OUTPATIENT CARE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DIGOXIN; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; DRUGS, CHINESE HERBAL; FEMALE; HEALTH SERVICES; HERB-DRUG INTERACTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS;

EID: 84877127571     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1359-6     Document Type: Article

References (48)

1. Chen FP, Chen TJ, Kung YY, Chen YC, Chou LF, Chen FJ, Hwang SJ (2007) Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res 7:26. doi: 10.1186/1472-6963-7-26
2. Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 11:42-49
3. Rossler W, Lauber C, Angst J, Haker H, Gamma A, Eich D, Kessler RC, Ajdacic-Gross V (2007) The use of complementary and alternative medicine in the general population: Results from a longitudinal community study. Psychol Med 37:73-84. doi: 10.1017/S0033291706008841
4. Siti ZM, Tahir A, Farah AI, Fazlin SMA, Sondi S, Azman AH, Maimunah AH, Haniza MA, Siti Haslinda MD, Zulkarnain AK, Zakiah I, Zaleha WCW (2009) Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med 17:292-299. doi: 10.1016/j.ctim.2009.04.002
5. Lim MK, Sadarangani P, Chan HL, Heng JY (2005) Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med 13:16-24. doi: 10.1016/j.ctim.2004.11.002
6. Barnes PM, Bloom B, Nahin RL (2007) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 12:1-24
7. Marques-Vidal P, Pecoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, Vollenweider P (2007) Prevalence and characteristics of vitamin or dietary supplement users in Lausanne. Switzerland: the CoLaus study. Eur J Clin Nutr doi:. doi: 10.1038/sj.ejcn.1602932
8. Reinert A, Rohrmann S, Becker N, Linseisen J (2007) Lifestyle and diet in people using dietary supplements: a German cohort study. Eur J Nutr 46:165-173. doi: 10.1007/s00394-007-0650-2
9. Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS (2006) Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 166:1968-1974. doi: 10.1001/archinte.166.18.1968
10. Yeh GY, Davis RB, Phillips RS (2006) Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 98:673-680. doi: 10.1016/j.amjcard.2006.03.051
11. Grant SJ, Yu SB, Kiat H, Chang D (2012) The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Publ Health 12:299. doi: 10.1186/1471-2458-12-299
12. Rochelle TL, Marks DF (2010) Medical pluralism of the Chinese in London: an exploratory study. Br J Health Psychol 15:715-728. doi: 10.1348/ 135910709X479195
13. Lai D, Chappell N (2007) Use of Traditional Chinese Medicine by older Chinese immigrants in Canada. Fam Pract 24:56-64. doi: 10.1093/fampra/cml058
14. Xu J, Yang Y (2009) Traditional Chinese medicine in the Chinese health care system. Health Policy 90:133-139. doi: 10.1016/j.healthpol.2008.09.003
15. Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT (2008) Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res 8:170. doi: 10.1186/1472-6963-8-170
16. Committee on Chinese Medicine and Pharmacy. Department of Health. Executive Yuan. http://www.ccmp.gov.tw/en/public/public.asp?selno = 44&relno = 44&level = C. Accessed 22 June 2012.
17. Permit license of Chinese Medications. Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan. http://www.ccmp.gov.tw/ information/license-search.asp?relno = 513&level = C. Accessed 22 June 2012.
18. Tatro DS (2010) Drug Interaction Facts. Wolters Kluwer Health/Facts & Comparisons, Saint Louis
19. Saw JT, Bahari MB, Ang HH, Lim YH (2006) Potential drug-herb interaction with antiplatelet/anticoagulant drugs. Complement Ther Clin Pract 12:236-241. doi: 10.1016/j.ctcp.2006.06.002
20. Chow L, Johnson M, Wells A, Dasgupta A, Chow L, Johnson M, Wells A, Dasgupta A (2003) Effect of the traditional Chinese medicines Chan Su, Lu-Shen-Wan, Dan Shen, and Asian ginseng on serum digoxin measurement by Tina-quant (Roche) and Synchron LX system (Beckman) digoxin immunoassays. J Clin Lab Anal 17:22-27
21. Cause of death in 2010. Department of Health, Executive Yuan. http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d = 84766&s = 1. Accessed 22 June 2012.
22. Chan HT, So LT, Li SW, Siu CW, Lau CP, Tse HF (2011) Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. J Cardiovasc Pharmacol 58:87-90. doi: 10.1097/FJC. 0b013e31821cd888
23. Williamson EM (2003) Drug interactions between herbal and prescription medicines. Drug Saf 26:1075-1092. doi: 10.2165/00002018-200326150-00002
24. National Health Research Institutes. National Health Insurance Research Database. http://www.nhri.org.tw/nhird/en/index.htm. Accessed 2 August 2011
25. Chung VC, Lau CH, Yeoh EK, Griffiths SM (2009) Age, chronic non-communicable disease and choice of traditional Chinese and western medicine outpatient services in a Chinese population. BMC Health Serv Res 9. doi: 10.1186/1472-6963-9-207
26. Mehta DH, Phillips RS, Davis RB, McCarthy EP (2007) Use of complementary and alternative therapies by Asian Americans. Results from the National Health Interview Survey. J Gen Intern Med 22:762-767. doi: 10.1007/s11606-007-0166-8
27. Lin HC, Yang WC, Lee HC (2008) Traditional Chinese medicine usage among schizophrenia patients. Complement Ther Med 16:336-342. doi: 10.1016/j.ctim.2007.11.001
28. Gozum S, Unsal A (2004) Use of herbal therapies by older, community-dwelling women. J Adv Nurs 46:171-178. doi: 10.1111/j.1365-2648.2003. 02970.x
29. Chen FN, Chao-Lee PD, Hsieh CL, Lin CC, Chiang HM, Lin HW, Chu HH, Tsai WC, Hou YC, Hung BL (2008) Survey on adult behavior and medication of Chinese and western medicine-based on the outpatients of a medical center in mid-Taiwan. J Int Chin West Med 10:25-34
30. Wittkowsky AK (2008) Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis 25:72-77. doi: 10.1007/s11239-007-0110-0
31. Mousa SA (2010) Antithrombotic effects of naturally derived products on coagulation and platelet function. Methods Mol Biol 663:229-240. doi: 10.1007/978-1-60761-803-4-9
32. Leung H, Hung A, Hui AC, Chan TY (2008) Warfarin overdose due to the possible effects of Lycium barbarum L. Food Chem Toxicol 46:1860-1862. doi: 10.1016/j.fct.2008.01.008
33. Wong AL, Chan TY (2003) Interaction between warfarin and the herbal product quilinggao. Ann Pharmacother 37:836-838. doi: 10.1345/aph.1C503
34. Health Department and National Chinese Medicine Management Office (1999) Chinese Materia Medica. Shanghai Science Technology Publication, Shanghai
35. Bin YS, Kiat H (2011) Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease. Evid Based Complement Alternat Med. doi: 10.1155/2011/632829
36. Lee GBW, Charn TC, Chew ZH, Ng TP (2004) Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 21:654-660. doi: 10.1093/fampra/cmh613
37. Shin YI, Yang CY, Joo MC, Lee SG, Kim JH, Lee MS (2008) Patterns of using complementary and alternative medicine by stroke patients at two university hospitals in Korea. Evid Based Complement Alternat Med 5:231-235. doi: 10.1093/ecam/nem025
38. Junhua Z, Menniti-Ippolito F, Xiumei G, Firenzuoli F, Boli Z, Massari M, Hongcai S, Yuhong H, Ferrelli R, Limin H, Fauci A, Guerra R, Raschetti R (2009) Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review. Stroke 40:2797-2804. doi: 10.1161/strokeaha.109.555227
39. Wu B, Liu M, Liu H, Li W, Tan S, Zhang S, Fang Y (2007) Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 38:1973-1979. doi: 10.1161/strokeaha.106.473165
40. Hsieh SC, Lai JN, Lee CF, Hu FC, Tseng WL, Wang JD (2008) The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Saf 17:609-619. doi: 10.1002/pds.1611
41. Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R (2008) Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc 108:483-494. doi: 10.1016/j.jada.2007.12.005
42. Bureau of National Health Insurance (2005) The National Health Insurance Statistics. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu = 11&menu-id = 296&webdata-id = 1942&WD-ID = 296. Accessed 1 September 2011.
43. Shih CC, Lin JG, Liao CC, Su YC (2009) The utilization of traditional Chinese medicine and associated factors in Taiwan in 2002. Chin Med J (Engl) 122:1544-1548
44. Liao HL, Ma TC, Li YC, Chen JT, Chang YS (2010) Concurrent Use of Corticosteroids with Licorice-Containing TCM Preparations in Taiwan: A National Health Insurance Database Study. J Altern Complement Med 16:539-544. doi: 10.1089/acm.2009.0267
45. Liao HL, Ma TC, Chiu YL, Chen JT, Chang YS (2008) Factors influencing the purchasing behavior of TCM outpatients in Taiwan. J Altern Complement Med 14:741-748. doi: 10.1089/acm.2007.7111
46. Shih SF, Lew-Ting CY, Chang HY, Kuo KN (2008) Insurance covered and non-covered complementary and alternative medicine utilisation among adults in Taiwan. Soc Sci Med 67:1183-1189. doi: 10.1016/j.socscimed.2008.06.011
47. National Center for Complementary and Alternative Medicine (2011) What Is Complementary and Alternative Medicine? http://nccam.nih.gov/health/whatiscam. Accessed 24 June 2012
48. National Center for Complementary and Alternative Medicine (2010) Traditional Chinese Medicine: An Introduction. http://nccam.nih.gov/health/ whatiscam/chinesemed.htm. Accessed 24 June 2012